Atai stock forecast.
Jun 5, 2023 · ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price.
1.04%. $183.15M. AMAM | Complete Ambrx Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study …WebBusiness, Economics, and Finance. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. CryptoAtai’s pipeline features five programs in clinical testing. The company’s lead candidate, RL-007, is being evaluated in a phase 2 clinical study as a potential treatment for schizophrenia.
This was the ETF and Ark Invest’s first purchase of ATAI stock since March 14. From March 14 to July 5, ATAI stock declined by 27%. After the recent purchases, ARKG now owns a total of 1.82 ...According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …
Find real-time JTAI - Jet.AI Inc stock quotes, company profile, news and forecasts from CNN Business.The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...
06:48 PM ET 11/23/2020. Atai Life Sciences, a company that backs Compass Pathways ( CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the ...ATAI / ATAI Life Sciences N.V. - Forecast and Price Target https://fintel.io/sfo/us/atai. See More. Bullish. Reply. Keep. Last Read. Share. Copy Message ...Dec 15, 2022 · What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low. STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.Atai Life Sciences Nv (ATAI) Share Price Forecast. Currently 15 wall-street analysts regularly analyze the financials of Atai Life Sciences Nv on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Atai Life Sciences Nv (ATAI) have a share price target of $12.32.
November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin.
The social networking company earned $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Twitter had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 0.82%. The firm's revenue was up 37.1% compared to the same quarter last year.
Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 21.00, with a high estimate of 50.00 and a low estimate of 6.60. The median estimate represents a +650.00% increase from the last price of 2.80. Analyst Recommendations.A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...Find real-time JTAI - Jet.AI Inc stock quotes, company profile, news and forecasts from CNN Business.
Find the latest TeraWulf Inc. (WULF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Aug 14, 2023 · Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years. Atai Life Sciences N.V. (ATAI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atai Life Sciences N.V. | Nasdaq: ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low …WebFind real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.04: Annual revenue (last year) $0.00: Annual profit (last year)Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.
ATAI Life Sciences N.V. Watch Set a price target alert Premarket Last Updated: Nov 15, 2023 8:18 a.m. EST Delayed quote $ 1.2900 0.04 2.79% Before Hours Volume: 2.23K …Web
Use our graph to track the performance of ATAI stocks over time. Share price volatility. Over the last 12 months, ATAI Life Sciences's shares have ranged in ...atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...The social networking company earned $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Twitter had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 0.82%. The firm's revenue was up 37.1% compared to the same quarter last year.ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.Analyst Recommendations on Atai Life Sciences N.V. Berenberg Bank Adjusts Atai Life Sciences Price Target to $11 From $18, Maintains Buy Rating. Mar. 29. MT. Credit Suisse Lowers Atai Life Sciences' PT to $9 From $11, Updates Model After Announced Workforce Reduction; Keeps Outperform Rating. Mar. 07.Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Dec 1, 2023 · Detailed statistics for Atai Life Sciences N.V. (ATAI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ...
Jul 14, 2021 · If you want to read our detailed analysis of these stocks, go directly to the 10 Best Psychedelic Stocks to Buy Now. 5. Cybin Inc. (OTC: CLXPF) Cybin Inc. (OTC: CLXPF) stock has returned more than ...
Nov 17, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...
Use our graph to track the performance of ATAI stocks over time. Share price volatility. Over the last 12 months, ATAI Life Sciences's shares have ranged in ...25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...NEW YORK and BERLIN, Aug. 10, 2023-- atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported second quarter 2023 ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information.Atai Life Sciences. ... Further clinical trial data will create volatility in CMPS stock. COMPASS Pathways 1-year price chart ... registering a CAGR of 16.8% during the forecast period of 2022 to ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...ALZN Stock 12 Months Forecast. $3.75. (160.42% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Alzamend Neuro in the last 3 months. The average price target is $3.75 with a high forecast of $6.50 and a low forecast of $1.00. The average price target represents a 160.42% change from the last price of $1.44.
How have NBSE shares performed in 2023? NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here.Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Instagram:https://instagram. ev harleyetf chinesebest dental insurance with no waiting perioddodge and cox global stock fund Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. what is prop firmlennox international Company profile for ATAI Life Sciences N.V. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ATAI description & address.Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ... top 10 stock to buy Vice President-Strategic Operations. The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter.CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.